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A B S T R A C T
The effect of 3b-hidroxihop-22(29)ene (3-BHO) on insulin and glucagon-like peptide 1 (GLP-1) secretion
as well as the mechanism of action of the compound in pancreatic islet on glucose homeostasis was
investigated. The data from in vivo treatment show that 3-BHO signiﬁcantly reduces the hyperglycemia
by increasing the insulin and GLP-1 secretion, as well as by accumulating hepatic glycogen in
hyperglycemic rats. In rat pancreatic b-cell, 3-BHO stimulates the glucose uptake, insulin vesicles
translocation to the plasma membrane and thus the insulin secretion through the involvement of
potassium channels (ATP- and Ca2+-dependent K+ channels) and calcium channels (L-type voltage-
dependent calcium channels (L-VDCC)). Furthermore, this study also provides evidence for a crosstalk
between intracellular high calcium concentration, PKA and PKC in the signal transduction of 3-BHO to
stimulate insulin secretion. In conclusion, 3-BHO diminishes glycaemia, stimulates GLP-1 secretion and
potentiates insulin secretion and increase hepatic glycogen content. Moreover, this triterpenemodulates
calcium inﬂux characterizing ATP-K+, Ca2+–K+ and L-VDCC channels-dependent pathways as well as PKA
and PKC activity in pancreatic islets underlying the signaling of 3-BHO for the secretory activity and
contribution on glucose homeostasis.
ã 2015 Elsevier Ltd. All rights reserved.
1. Introduction
The triterpenes are a wide class of metabolites synthesized and
distributed in plants and can be found as free acids or aglycones.
They are available in a large number of essential oils, resins and
waxes and provide a range of commercial products including
pharmaceutical agents [1]. Concerning to the structures, the
triterpenes are grouped mainly into euphanes, taraxanes, ole-
ananes, lupanes, ursanes, baccharanes and hopanes. In higher
plants, their presence depend on the species, season and the
environment of cultivation [2,3]. The species Croton heterodoxus
Baillon belongs to the genus Croton, which is part of the
Euphorbiaceae family. Many Euphorbiaceae are well known in
different parts of theworld as toxic and/ormedicinal. The diversity
of the effects already described is a reﬂex of the high chemical
diversity of this plant group. The genus Croton comprises around
1300 species of trees, shrubs and herbs distributed in tropical and
subtropical regions of both hemispheres, including some species
that have been used in popular medicine for many applications.
The genus is rich in constituents with biological properties and the
terpenoids are the predominant secondary metabolite constitu-
ents, chieﬂy diterpenoids. Triterpenoids, either pentacyclic or
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steroidal, have frequently been reported for Croton species [4].
Taking into account the beneﬁts of triterpenes as potent
compounds that may be useful therapy for diabetes mellitus
[2,5,6], few studies demonstrate the mechanism of action of these
compounds in speciﬁc targets involved on glucose homeostasis.
The glycaemia is highly regulated by glucose uptake in insulin
target tissues (muscle and adipose tissue) and endogenous glucose
synthesis (liver and kidney) [7]. The glucose metabolism and its
control starts in the intestine, where several processes work
together in order to guarantee that the diet carbohydrates
are efﬁcientlymetabolized and absorbed. These processes involves
the intestinal enzymes activities such as disaccharidases as well as
the presence of the functioning sugar transporters at the enter-
ocytes plasma membrane such as the glucose transporters SGLT1
and GLUT2 [7–9]. Additionally, the endocrine cells of the intestine
presents an important role on glucose metabolism since they
synthesize and release hormones (incretins) such as glucagon-like
peptide-1-(7-36) amide (GLP-1), a hormone secreted by
the intestinal L-cells in response to meals that potentiates the
glucose-stimulated insulin secretion (GSIS) and inﬂuences the
whole body glucose metabolism [10].
Glucose is the main physiological secretagogue of insulin from
pancreatic b-cells [11]. The abrupt increase of blood glucose (from
3mmol/L to 22mmol/L) after a meal take to a biphasic glucose-
stimulated insulin secretion. The ﬁrst phase of insulin secretion
occurs around 5–6min after stimulation and the second phase of
insulin release is characterized by a sustained increase of the
hormone over 60min [12,7]. The hyperglycemia induces the
uptake of glucose at the b-cell through GLUT2 and its metabolism
raising the ATP/ADP ratio. The high intracellular ATP levels closes
ATP-dependent potassium channels (KATP channels) at the plasma
membrane and triggers a membrane depolarization that results in
the opening of the membrane voltage-activated Ca2+ channels
(L-VDCC) increasing calcium inﬂux to the b-cells [13]. The high
cytosolic Ca2+ promotes the insulin secretory granules transloca-
tion and exocytosis culminating on the increase of insulin
secretion. The insulin vesicles translocation and exocytosis
involves a soluble N-ethylmaleimide-sensitive factor attachment
protein receptor (SNARE) fusion machinery that can be modulated
by different secondmessengers depending onwhich kind of signal
pathway are activated and or modulated on b-cells. Several kinase
substrates have been localized to b-cell secretory vesicles or
membrane fractions, which might be involved in vesicle trafﬁck-
ing, priming, and fusion processes which are demonstrated to be
regulated by the PKA and PKC signaling pathways [14–17].
In recent years, there has been a growing interest in anti-
diabetic agents fromnatural sources, especially those derived from
plants, because the compounds of plants with ethnomedicinal
backgrounds in a generalway have low toxicity and few side effects
than synthetic medicines [18,19,5]. Therefore, the aim of the
present study was to investigate the role of 3-BHO on glycaemia
and the mechanism of action on insulin vesicles translocation and
insulin secretion by b-cell. In addition, the toxicity evaluation was
carried out in in vivo and in vitro approaches over the time of
experiments.
2. Materials and methods
2.1. Chemicals
Bovine serum albumin (BSA), sitagliptin phosphate monohy-
drate, collagenase Type V, 1,2-bis(2-aminophenoxy)ethane-N,N,N0,
N0-tetraacetic acid tetrakis (acetoxymethyl ester) (BAPTA-AM),
nifedipine, apamin, diazoxide, glibenclamide, stearoylcarnitine
chloride (ST), N-[2-(p-bromocinnamylamino)ethyl]-5-isoquinoli-
nesulfonamide (H-89) were purchased from Sigma–Aldrich
(St. Louis, MO, USA). Regular human insulin (100 IU/mL; Humulin)
was purchased from a commercial source. The enzyme-linked
immunosorbent assay (ELISA) for the quantitative determination
of rat insulin (catalog no. EZRMI-13K) was obtained fromMillipore
(St. Charles, MO, USA). Glucagon-like peptide (GLP-1) assay (ELISA)
for the quantitative determination of rat GPL-1 (Cat. # EZGLP1T-
36K), obtained from Millipore (St. Charles, MO, USA), [U-14C]-2-
deoxy-D-glucose (14C-DG), speciﬁc activity 9.25GBq/mmol, [45Ca]
CaCl2 (sp. act. 321KBq/mg Ca2+), and biodegradable liquid
scintillation ﬂuid were obtained from PerkinElmer Life and
Analytical Sciences (Boston, MA, USA). All other chemicals were
of analytical grade.
2.2. Plant material
2.2.1. Isolation and chemical characterization of the triterpene 3-BHO
The aerial parts of C. heterodoxus Baillon were collected at
Pitangui river refuge, with UTM coordinates 593095 and 7231847,
in the General Fields region, Ponta Grossa city, PR, in April and June
2010 in partnership with the project “Identiﬁcation of species for
restoration of ecosystems impacted by forestry surrounding of
Alagados fountain”, under the coordination of Rosemeri Segecin
Moro, fromde State University of Ponta Grossa, PR, Brazil. The plant
material was identiﬁed by the botanist Daniel de Barcellos
Falkenberg from the Department of Botany of the Federal
University of Santa Catarina. A voucher specimen was deposited
in the FLOR herbarium and registered with the number 37689.
The triterpene 3-BHO was isolated from the hexane fraction of
the crude hydroalcoholic extract obtained of the C. heterodoxus
(aerial parts) as following: the crude hydroalcoholic extract from
stems of the C. heterodoxus (152.51 g) was re-suspended in ethanol
[15%] and water [85%], and fractionated by liquid–liquid extraction
using hexane and EtOAc to afforded 29.27 g of the hexane fraction,
46.60 g of the EtOAc fraction and 41.75 g of the insoluble residue.
The hexane fraction (25.44 g) was chromatographed on a silica gel
60 (Vetec, 0.063–0.2mesh) column and eluted with hexane and
increasing amounts of ethyl acetate (0–100%) to give 155 fractions
(125mL each). Fractions 24–25 (85:15 hexane–EtOAc) were
combined and puriﬁed by recrystallization on hexane/EtOAc-4:1
to yield 0.62 g of the triterpene 3-BHO that was identiﬁed as 3b-
hydroxyhop-22(29)-ene through detailed NMR spectral analysis
including 1H-1H COSY, HMQC and HMBC and comparison with
literature dates [20–22]: MM 426.72 gmol1; m.p 248.5 C; Rf (tlc)
0.50 (80:20 n-hexane–EtOAc); IVKBrymaxcm1 3422; 29172849;
1733. NMR 1H (CDCl3) d: 1.68 (m, H-1); 0.95 (m, H-2); 3.20 (dd,
J =11.52 and 5.27Hz, H-3); 0.67 (m, H-5); 1.68 (m, H-6); 2.34 (m, H-
7); 1.25 (m, H-9); 2.12 (m, H-11); 1.55 (m, H-12); 1.22 (m, H-13);
1.38 (m, H-15); 0.90 (m, H-16); 0.65 (m, H-17); 2.00 (m, H-19); 1.43
(m, H-20); 1.45 (m, H-21); 1.03 (s, H-23); 0.76 (s, H-24); 0.79 (s, H-
25); 0.97 (s, H-26); 0.94 (s, H-27); 0.72 (s, H-28); 4.78 (sl, H-29);
1.75 (s, H-30). NMR 13C (CDCl3) d: 38.8 (C-1); 31.9 (C-2); 79.0 (C-3);
29.4 (C-4); 55.1 (C-5); 18.4 (C-6); 33.3 (C-7); 41.7 (C-8); 50.3 (C-9);
37.1 (C-10); 21.0 (C-11); 22.7 (C-12); 49.4 (C-13); 42.0 (C-14); 33.6
(C-15); 21.6 (C-16); 54.8 (C-17); 44.8 (C-18); 41.9 (C-19); 23.9 (C-
20); 46.4 (C-21); 148.7 (C-22); 28.0 (C-23); 16.7 (C-24); 14.1 (C-25);
16.1 (C-26); 16.6 (C-27); 15.8 (C-28); 110.1 (C-29); 25.0 (C-30). This
compound was previously isolated from Euphorbia lathyris [20,21]
and Rhododendron lepidotum [23] but it is the ﬁrst time that this
compound was isolated and identiﬁed at C. heterodoxus. A
representative HPLC chromatogram of the triterpene 3-BHO is
included as Supplementary material. Brieﬂy, the homogeneity of
the triterpene 3-BHO was determined by HPLC on an Agilent 1260
Inﬁnity using a 4.6mm150mm5mm Phenomenex Luna C18
column. The column temperature was maintained at 25 C and the
ﬂow ratewas 0.5mL/min. Mobile phase was acetonitrile and water
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[70:30] as an isocraticmethod. The triterpenewas detected using a
diode array detector at 210nm.
2.3. Animals
Male albinoWistar rats, 50–55 days old (180–210 g), were used.
Rats were bred in animal facility and housed in an air-conditioned
room (approximately 21 C) with controlled lighting (lights on
from06:00 to 18:00h). The animalsweremaintainedwith pelleted
food (Nuvital, Nuvilab CR1, Curitiba, PR, Brazil), while tap water
was available ad libitum. Fasted rats were deprived of food for 16h
but allowed free access to water. All the animals were carefully
monitored and maintained in accordance with the local Ethical
Committee for Animal Use (Protocol CEUA-UFSC PP00414).
2.4. Oral glucose tolerance curve
Fasted ratswere divided into seven groups of six animals. Group
I, normal rats; group II hyperglycemic rats that received glucose
(4 g/kg; 8.9M – glucose concentration necessary to induce the
hyperglycemic status); group III, hyperglycemic rats that received
the vehicle, 2.5% Tween 80; group IV, hyperglycemic rats that
received 0.1mg/kg of compound 3-BHO; group V, hyperglycemic
rats that received 1mg/kg of compound 3-BHO; group VI,
hyperglycemic rats that received the 10mg/kg of compound
3-BHO; group VII, hyperglycemic rats that received 0.05 IU of
insulin by i.p. route (positive control group). The glycaemia was
measured before any treatment (zero time). Immediately, rats
received the treatment (vehicle or 3-BHO) and after 30min they
were overloaded with glucose. The glucose tolerance curve was
initiated just after the glucose overload and then the glycaemia
was measured at 15, 30, 60 and 180min. All treatments were
administered by oral gavage. Blood samples from the tail veinwere
collected, centrifuged and the serum was used to determine the
glycaemia by the glucose oxidase method [24] and the insulin
levels.
2.5. Insulin serum measurements
The insulin levels were measured by ELISA according to the
manufacturer’s instructions. The range of values detected by this
assay was 0.2–10ng/mL. The intra- and inter-assay coefﬁcients of
variation for insulin were 3.22 and 6.95, respectively, with a
sensitivity value of 0.2 ng/mL. Insulin levels were estimated by
means of colorimetric measurement at 450nmwith an ELISA plate
reader (Organon Teknika, Roseland, NJ, USA) through interpolation
from a standard curve. Samples were analyzed in duplicate and
results were expressed as ng of insulin serummL1. Analyses of
area under curve (AUC) obtained during oral glucose tolerance
curve (from zero to 60min), were used to calculate insulinogenic
index (Dins/Dgluc) [25,26].
2.6. GLP-1 serum measurements
For measurements of GLP-1 serum levels, fasted rats were
divided into two groups of six animals: group I, rats that received
only sitagliptin 10mg/kg (control); and group II, rats that received
sitagliptin 10mg/kg and 3-BHO 10mg/kg; sitagliptin and 3-BHO
were administered 60min and 30min before the oral hyperglyce-
mia induction (Glucose 8.9M p.o.), respectively. The blood was
collected at 0, 15, 30 and 60min after hyperglycemia induction,
centrifuged and the serum obtained used for measurement of GLP-
1 by ELISA, in according to the manufacturer’s instructions. The
range of values detected by this assay was 4.1–1000pM. The intra-
and inter-assay coefﬁcients of variation for GLP-1 were <5% and
<12%, respectively, with a sensitivity value of 1.5 pM. The GLP-1
level was estimated by means of absorbance measurement at 450
and 590nm. Samples were analyzed in duplicate and results were
expressed as pM of GLP-1 serum [27].
2.7. Glycogen content measurements
The liver without perfusion was harvested from normal
rats, hyperglycemic and hyperglycemic rats treated with 3-BHO
(0.1,1.0 and 10mg/kg by oral gavage) and the glycogen content was
immediately determined after 180min of glucose overload (4 g/
kg). The glycogenwas isolated from the tissue as described by [28]
and the results were expressed as mg of glycogen/g of tissue [5].
2.8. Pancreatic islet isolation
The rat pancreas was visualized by way of a central abdominal
incision. The bile duct was clamped at the tip of the duodenum and
cannulated at a point sufﬁciently proximal to the liver. Krebs
Ringer-bicarbonate buffer with a composition of 122mM NaCl,
3mM KCl, 1.2mM MgSO4, 1.3mM CaCl2, 0.4mM KH2PO4, and
25mM NaHCO3 supplemented with 8mM HEPES (KRb-HEPES)
medium was introduced slowly into the bile duct by syringe until
the pancreas was clearly distended. The pancreas was then gently
removed and then kept in Petri dishes with KRb-HEPES medium.
The pancreatic tissue was cut into small pieces (ca. 22mm) and
incubated in plastic tubes in 1mL of KRb-HEPES medium
supplemented with collagenase (3mg). After incubation the
mixture was transferred to a conical tube (11015mm), resus-
pended in 10mL of KRb-HEPES collagenase free medium and
centrifuged at room temperature for 3min at 45 g in an Excelsa
Baby centrifuge (model 206), FANEM, São Paulo, SP, Brazil. The
supernatant was discarded and the sediment resuspended in fresh
KRb-HEPES medium. This washing procedure was repeated ﬁve
times; in the last two washings the islets were allowed to settle
without centrifugation. Aliquots (100mL) of the ﬁnal sediment
with the isolated islet were transferred to the tubes with the
incubation medium KRb-HEPES [29,30].
2.9. Studies on 14C-glucose uptake in rat pancreatic islet
For the [U-14C]-2-deoxy-D-glucose (14C-DG) uptake experi-
ments, the pancreatic islets isolated of euglycemic rats were used.
The islets were pre-incubated (30min) and incubated (time of
treatment) at 37 C in Krebs Ringer-bicarbonate (KRb) bufferwith a
composition of 5.6mM glucose, 122mM NaCl, 3mM KCl, 1.2mM
MgSO4, 1.3mM CaCl2, 0.4mM KH2PO4, and 25mM NaHCO3 and
bubbled with O2/CO2 [95%:5%, v/v] until pH 7.4. The time-course of
glucose uptake in the presence 10nM 3-BHO or KRb buffer (basal)
was carried out at 10 and 30min. 14C-DG (0.1mCi/mL; 0.12nM) and
3-BHO treatment (1010, 109, 108, 107, 106M) was added to
each sample during the incubation period (10 or 30min). Samples
were processed accordingly [25]. Aliquots were used for the total
Table 1
The ratio of cytoplasmic insulin vesicles per b-cell in the presence of 3-BHO
(100nM) (treated) or absence (basal) in ﬁrst and second phase of insulin secretion.
Incubation time=5 and 20min with/without 3-BHO; n =29 vesicles for hypergly-
cemic basal group at 5min; n =29 vesicles for hyper +3-BHO group at 5min; n =16
vesicles for hyperglycemic basal group at 20min and n =23 vesicles for hyper + 3-
BHO at 20min. Triplicates of each group were analyzed.
Time 5min 20min
Hyper Hyper +3-BHO Hyper Hyper + 3-BHO
Cytoplasmicvesicles/cell 4.03 1.19 1.62 0.18
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protein quantiﬁcation by the [31] and results were expressed as
nmol glucose units/mg of protein.
2.10. Calcium uptake experiments
The isolated islets were pre-incubated for 60min in a Dubnoff
metabolic incubator to equilibrate in KRb-HEPES buffer containing
5mM glucose and 0.1mCi/mL 45Ca2+ at 37 C, pH 7.4 and gassed
with O2:CO2(95:5; v/v). The time-course of calcium inﬂux in the
presence of 100nM3-BHO or KRb-HEPES buffer (basal) was carried
out at 30, 60, 300, 600 and 900 s. After that, the islets were
incubated for 10min in KRb-HEPES without (basal) or with the 3-
BHO (1010,109,108,107,106M). In some experiments, channel
antagonists, channel agonist, chelant of calcium or protein kinases
inhibitors were added during the last 15min of incubation before
the treatment and maintained during the entire incubation period
(see). The following drugs were used: glibenclamide (20mM) [30],
apamin (0.1mM) [32], diazoxide (250mM) [30], nifedipine (1mM)
[30,33], BAPTA-AM (50mM), H-89 (10mM) [34], and ST (0.1mM)
[35]. The incubation was halted using the technique reported by
[36] with modiﬁcations [30]. Cold buffer (1mL with lanthanum
chloride (10mM) at 2 C was added to the samples to stop calcium
ﬂuxes. The tubes were centrifuged for 1min at 45 g. The
supernatant was preserved and the islets were washed twice in
cold lanthanum chloride solution. The islets were added to screw-
cap tubes containing 300mL of 0.5M NaOH solution and boiled at
100 C for 5min. Aliquots of 50mLwere taken fromeach sample for
the measurement of radioactivity in scintillation liquid Optiphase
Hisafe III (Wallac Oy, Turku, Finland) in an LKB rack beta liquid
scintillation spectrometer (model LS 6500; Multi-Purpose Scintil-
lation Counter-Beckman Coulter, Boston, USA) and 5mL aliquots
were used for protein quantiﬁcation by the Lowry method [31].
2.11. Transmission electron microscopy
For the observation under the transmission electron micro-
scope (TEM), pieces of rat pancreas were incubated in the presence
of 3-BHO (100nM) for 5 or 20min and were ﬁxed overnight with
2.5% glutaraldehyde in 0.1M sodium cacodylate buffer (pH 7.2)
plus 0.2M sucrose [37]. The material was post-ﬁxed with 1%
osmium tetroxide for 3h, dehydrated in a graded acetone series
and embedded in Spurr’s resin. Then, thin sections were stained
with aqueous uranyl acetate followed by lead citrate according to
Reynolds [38]. Four replicates were prepared for each
[(Fig._1)TD$FIG]
Fig.1. Triterpene improves glucose tolerance curve and stimulates GLP-1 secretion. Values are expressed asmean S.E.M. with n =5. Signiﬁcant at ***p0.001 and **p0.01
compared to the respective value for hyperglycemic basal group.
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experimental group; two samples per replicate were examined
under TEM (Jeol JEM1011 at 80kV) at the Central Laboratory of
Electron Microscopy (LCME, UFSC, Brazil). In order to evaluate the
ratio of cytoplasmic insulin vesicles perb-cell [39], an isolated islet
was sectioned and the vesicles of b-cells were counted. So, the
total number of vesicles was divided by the number of b-cells in
the islet. Similarities based on the comparison of individual
treatments with replicates suggested that the ultra-structural
analyses were reliable (Table 1).
2.12. Calcium serum measurements and lactate dehydrogenase
Blood samples and the serum were used to determine
extracellular lactate dehydrogenase (LDH) after 180min of oral
3-BHO in vivo treatment (10mg/kg). KRb solution was also used to
determine extra and intracellular LDH after 10min of in vitro
treatment (100nM). Calcium serum levels were determined at
zero and 180min after 10mg/kg 3-BHO oral treatment or in the
absence in the hyperglycemic basal group. The calcium
determination was measured according to the manufacturer’s
instructions [5].
2.13. Data and statistical analysis
Data were expressed as mean S.E.M. One and two-way
analysis of variance (ANOVA) followed by Bonferroni post-test or
unpaired Student’s t-test were used to determine whether there
were signiﬁcant differences between groups. Differences were
considered signiﬁcant at p0.05.
3. Results
3.1. Effect of 3-BHO on glycemia and on GLP-1 secretion
Fig. 1A shows the structure of the triterpene 3b-hidroxihop-22
(29) ene (3-BHO) and Fig. 1B shows the proﬁle of serum glucose
levels in hyperglycemic rats after oral treatment with 3-BHO (0.1, 1
[(Fig._2)TD$FIG]
Fig. 2. Triterpene stimulates insulin secretion. Thewhite arrows indicate the insulin granules andN indicates the nucleus. Values are expressed asmean S.E.M. with n =5 for
each group. Statistically signiﬁcant at **p0.01 and ***p0.001 compared to the hyperglycemic basal group.
116 A.J.G. Castro et al. / Journal of Steroid Biochemistry & Molecular Biology 150 (2015) 112–122
and 10mg/kg). The acute effect of the compound was able to
decrease signiﬁcantly the serum glucose levels in all doses tested
during the period studied when compared with the respective
hyperglycemic basal group. The sustained effect on serum glucose
loweringwas observedwith 1 and 10mg/kgwith triterpene 3-BHO
treatment improving signiﬁcantly the glucose tolerance. Also,
insulin diminished signiﬁcantly the serum glucose levels when
compared to the hyperglycemic control group over the period
studied. As expected, the vehicle 2.5% Tween 80 did not modify
the glycemia over the period studied when compared to the
hyperglycemic basal group. Also, as it was expected, the
euglycemic control group did not show a signiﬁcant change on
the proﬁle of glycemia over the time studied. In percentage terms,
the highest reductions on glycemia were detected at the shorter
periods (15 and 30min) after the treatmentwith 0.1 and 1mg/kg of
triterpene 3-BHO (around 16% and 17%, around 35% and 27%,
respectively). This rapid effect on glycemia seems to be supported
by an acute action of the compound at the intestinal level, since the
serum GLP-1 levels were signiﬁcantly increased at 15min,
[(Fig._3)TD$FIG]
Fig. 3. Triterpene increase hepatic glycogen content. Values are expressed as
mean S.E.M. with n =5 for each group. Statistically signiﬁcant at ***p0.001
compared to the hyperglycemic basal group.
[(Fig._4)TD$FIG]
Fig. 4. Time-course and concentration response curve of the triterpene on glucose uptake in rat pancreatic islets. Pre-incubation time=30min; incubation time=10 and/or
30min. Values are expressed as mean S.E.M. n =6 in duplicate for each group. Signiﬁcant at *p0.05 and ***p0.001 in relation to 10min basal group and ###p0.001 in
relation to 30min basal group.
[(Fig._5)TD$FIG]
Fig. 5. Time-course and concentration response curve of the triterpene on calcium
inﬂux in rat pancreatic islets. Values are expressed as mean S.E.M. n =6 in
duplicate for each group. Signiﬁcant at **p0.01 and ***p0.001 in relation to
basal group.
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compared with the hyperglycemic plus sitagliptin positive basal
group (Fig. 1C).
3.2. Effect of 3-BHO on insulin secretion and insulin vesicles
translocation
Taking into account the antihyperglycemic effect of triterpene
3-BHO after the in vivo treatment, the serum insulin levels were
determined in fasted rats after an oral glucose overload. As it was
expected, glucose induced-insulin secretion corroborated the
classical secretagogue effect of glucose. In addition, the treatment
with 3-BHO signiﬁcantly potentiated the insulin secretion induced
by glucose over the time evaluated. Interestingly, the increases of
8%, 20% and 10% of insulin secretion in the presence of 3-BHOwere
maintained invariable during all the period studied, demonstrating
a sustained insulin secretion (Fig. 2A), with an insulinogenic index
(II) about 0.56 ng/dL (control) and 0.754ng/dL (3-BHO).
The participation of 3-BHO on the insulin vesicles translocation
to the plasma membrane of b-cells was highlighted by electronic
microscopy approach. The representative picture (Fig. 2B, panels
(a) and (b)) shows the insulin granules accumulated around the
plasma membrane in the basal group. After the pancreatic islets
incubation with 100nM of triterpene 3-BHO during 5min it was
observed an increase on insulin granules release (around 70%)
when compared with the respective hyperglycemic basal group
(panel c). Additionally, after 20min of incubation in the presence of
3-BHO, the secretion of insulin granules released from b-cells was
around 88% compared with the respective hyperglycemic basal
group (panel d) (Table 1).
3.3. Effect of 3-BHO on hepatic glycogen content
Fig. 3 shows the effect of 3-BHO after the in vivo treatment on
hepatic glycogen content. All doses of 3-BHO administered by oral
gavage increased signiﬁcantly the glycogen content in the liver
measured at 3h after treatment.
3.4. Effect of 3-BHO on 14C-glucose uptake on pancreatic islets
The glucose uptake by GLUT2 and its metabolism has a central
role in glucose-induced insulin secretion in b-cells. Fig. 4A shows
that 3-BHO (10nM) acutely stimulates glucose uptake in pancre-
atic islets at 10 and 30min of incubation. Furthermore, 3-BHO
exhibited a bell-shape dose-response curve on glucose uptake at
pancreatic islets and its effect was signiﬁcant from 109 to 106M
after 30min of pancreatic islets incubation (Fig. 4B).
3.5. Effect of 3-BHO on 45Ca 2+ inﬂux on pancreatic islets
The ionic intracellular calcium augment is mandatory for
insulin secretion byb-cells. So, the role of 3-BHO on calcium inﬂux
and themechanism of action of the compound on insulin secretion
were carried out in isolated pancreatic islets. After the calcium
equilibrium obtained through 60min of islet incubationwith 45Ca2
+, calcium inﬂux was then measured at 30 s and at 1, 5, 10 and
15min without (basal) or with 3-BHO (100nM). A stimulatory
effect of 3-BHO on calcium inﬂuxwas observed in a typical spike of
calcium inﬂux at 10min, comparedwith the respective basal group
(Fig. 5A). The dose that exhibited a signiﬁcant calcium inﬂux
(around 68%) was used for the further in vitro studies (Fig. 5B).
3.6. Involvement of potassium channels on the stimulatory effect of
3-BHO on 45Ca 2+ inﬂux
To study the involvement of K+ channels in the stimulatory
effect of 3-BHO on calcium inﬂux in pancreatic islets, 20mM
glibenclamide (an ATP-K+ potassium channel blocker) and 0.1mM
apamin (a Ca2+–K+ channel blocker) and 250mM diazoxide (a
potassium channel activator), were used. As expected, glibencla-
mide signiﬁcantly increased the calcium inﬂux after 10min of in
vitro incubation. Additionally, during the incubation of the
pancreatic islets with 3-BHO in the presence of glibenclamide
any additional stimulatory effect on calcium inﬂux was observed
(Fig. 6A). Furthermore, Fig. 6B shows that apamin did not change
the basal calcium inﬂux. However, the stimulatory effect of the
triterpene on calcium inﬂux in the presence of apamin was
completely blocked. Also, diazoxide signiﬁcantly decreased the
[(Fig._6)TD$FIG]
Fig. 6. The stimulatory effect of triterpene on calcium inﬂux involves the activity of
potassium channels. Values are expressed as mean S.E.M. n =6 in duplicate for
each group. Signiﬁcant to **p0.01 and ***p0.001 in relation to basal group.
Signiﬁcant to #p0.05 and ###p0.001 in relation to 3-BHO group.
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calcium inﬂux stimulated by 3-BHO on isolated pancreatic islets
(Fig. 6C).
3.7. Involvement of calcium on the stimulatory effect of 3-BHO on 45Ca
2+ inﬂux
Additionally, the implication of L-type voltage-dependent
calcium channels (L-VDCCs) in the mechanism of action of
3-BHO on calcium inﬂux on pancreatic islets was studied.
Fig. 7A shows that nifedipine did not change the basal level of
calcium inﬂux. However, nifedipine nulliﬁed the stimulatory effect
of 3-BHO on calcium inﬂux.
The inﬂuence of calcium from intracellular stocks on the
stimulatory effect of 3-BHO in calcium inﬂux was studied by using
an intracellular calcium chelator, BAPTA-AM. Fig. 7B shows that
BAPTA-AMdid not alter the basal level of calciumuptake. However,
the equilibrium of calcium from stocks is crucial for the complete
stimulatory effect of 3-BHO on calcium inﬂux since on presence of
the calcium chelator the stimulatory effect of 3-BHO was
completely blocked.
3.8. Inﬂuence of protein kinase A and C on the stimulatory effect of
3-BHO on 45Ca 2+ inﬂux
Involvement of PKA and PKC in triterpene-induced calcium
inﬂux at isolated pancreatic islets were carried out. The treatment
of rat islets either with H-89, an inhibitor of PKA catalytic activity,
or with ST, an inhibitor of PKC activity, nulliﬁed the stimulatory
effect of 3-BHO on calcium inﬂux. These results showed that the
inhibitors used did not change the basal level of calcium inﬂux
(Fig. 8).
3.9. Effect of 3-BHO on LDH and calcium serum levels
In order to verify a potential toxicity of this compound, the LDH
and calcium serum levels were evaluated after the oral treatment
with 3-BHO. The dose of 10mg/kg orally administrated was not
able to change neither serum LDH nor calcium serum levels
(Fig. 9A and B), indicating that in this experimental condition the
3-BHO administration by oral gavage was not able to exhibit toxic
effects. Additionally, the in vitro effect of 3-BHO on intra (Fig. 9C)
and extracellular (Fig. 9D) LDH activity was evaluated after
incubation of 3-BHO (100nM) for 10min. From these data it was
detected that lactate was not accumulated in pancreatic islet and
3-BHO was not toxic in this experimental condition.
4. Discussion
The compound 3-BHO is a triterpene isolated for the ﬁrst time
from C. Heterodoxus leaves and recently identiﬁed by [40]. The
antidiabetic effect of 3-BHO in an acute oral treatment was
characterized by improving the glucose tolerance curve and its
efﬁciency on insulin secretion. In addition, 10mg/kg 3-BHO
exhibited a proﬁle of serum glucose lowering similar to that
observed for the insulin positive control. This effect on glucose
homeostasis is in line with those described for oleanolic acid and
b-amyrin and recently also for betulinic and ursolic acids studied
in a similar approach [41,42,5,6]. The increased insulin release as
well as the sustained high insulin levels throughout the period
[(Fig._7)TD$FIG]
Fig. 7. The stimulatory effect of triterpene on calcium inﬂuxmodulates intracellular
calcium in rat pancreatic islets. Values are expressed as mean S.E.M. n =6 in
duplicate for each group. Signiﬁcant ***p0.001 in relation to basal group.
Signiﬁcant to ###p0.001 in relation to 3-BHO group.
[(Fig._8)TD$FIG]
Fig. 8. Protein kinases mediates the stimulatory effect of the triterpene on calcium
inﬂux in rat pancreatic islets. Values are expressed as mean S.E.M. n =6 in
duplicate for each group. Signiﬁcant ***p0.001 in relation to basal group.
Signiﬁcant to ###p0.001 in relation to 3-BHO group.
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studied induced by 3-BHO in hyperglycemic rats seem to be
potentiated by GLP-1 secretion during the transit of this triterpene
on intestine. The increase on GLP-1 serum levels measured just
after 3-BHO oral treatment may be related with the potentiated
insulin secretion detected from 15 to 60min. This hormone is a
potent incretin synthetized and secreted by L-cells type in
intestine in response to meals and acts on b-cells stimulating
the insulin secretion [43]. Also, 3-BHO was able to accumulate
hepatic glycogen content in a short-term effect similar of those
reported for other triterpenes, reinforcing their inﬂuence on
carbohydrate metabolism [44,45,5,6].
In awhole, the present data point that the triterpene 3-BHO can
exert its effects reducing serum glucose levels by inﬂuencing GLP-1
and insulin secretion. These results are reinforced by the
triterpene’s stimulatory effect on insulin granules translocation.
It worthwhile to pay attention that the insulinogenic index of
3-BHO (II = 0.754ng/dL) points to a potential insulin secretagogue
when compared to both, the insulinogenic index (II) of the
hyperglycemic control group as well as to the lupane-type
triterpene betulinic acid group (II = 0.61ng/mL), measured in a
similar approach [5].
The b-cells are highly sensitive to the elevation of extracellular
glucose levels and efﬁciently take up glucose. Inside the cell, the
glucose is efﬁciently metabolized resulting in an increase of the
ATP/ADP ratio that affects the activity of diverse potassium and
calcium membrane channels [7]. The stimulatory effect of 3-BHO
on glucose uptake (Fig. 4A) is in accordance to the sustained insulin
serum levels (Fig. 2A) and the involvement of KATP channels on the
calcium inﬂux at pancreatic islets shown in Fig. 6A–C. These results
are in linewith the classical pattern of insulin secretion observed in
perfused rat pancreas and also reported for human subjects in
response to high glucose [47,48,49].
Among the several kind of potassium channels expressed in the
pancreatic b-cell the ones critical to insulin secretion are the KATP
channel, the Ca2+–K+ channel and the delayed rectiﬁer channel Kv
[50]. The participation of KATP channels was well evidenced by
using glibenclamide and these results were corroboratedwhen the
action of 3-BHO was completely blocked in the presence of
diazoxide. Also, the inﬂuence of Ca2+–K+ channels on the signal
transduction of 3-BHO was characterized since apamin abrogated
the stimulatory effect of 3-BHO on calcium inﬂux.
The abrupt increase in intracellular calcium (by inﬂux and from
stocks) induced by 3-BHO is in agreement with the ionic events
characterized by triggering cellular secretion [51]. The involve-
ment of extracellular calcium mediated by the activation of
voltage-dependent Ca2+ channels, mainly the dihydropyridine
sensitive L-type Ca2+ channels contributes to a localized intracel-
lular calcium concentration that also can be strongly augmented by
calcium from stocks to culminate on insulin vesicles exocytosis and
insulin secretion [49,51,52]. It has already been proved that these
potassium and calcium channels are involved on the classical
mechanism of the glucose induced insulin secretion. Considering
that, compounds that can act through cellular targets that are
physiologically involved in the insulin secretion such it is described
in the literature [43,41,46,5] and we observed to the triterpene
3-BHO at the present study represent a potential tool to the
management of the glucose homeostasis.
Despite the well-known depolarization–secretion coupling
initiated by the metabolism of glucose, it is also possible activate
intracellular signaling pathways that lead to the activation of
protein kinases such as PKC and PKA. Besides these protein kinases
modulate cell excitability, calcium inﬂux and gene expression
recently they have been described as modulators of the secretory
machinery. In pancreaticb-cells, PKA activation potentiates insulin
[(Fig._9)TD$FIG]
Fig. 9. Triterpene neither affect the cell surviving activity nor serum calcium in rat islets. Values are expressed as mean S.E.M. with n =5 for each group.
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secretion by increasing the total number of vesicles that are
available for release [53,54]. Also, increased intracellular calcium
activates PKC isoenzymes and release insulin. In addition, glucose
also activates PKC directly leading to the insulin release [55,56].
The participation of PKA and PKC on signal transduction of 3-BHO
on pancreatic islets for the release of insulin granules seem to be
evident since the calcium inﬂux was completely blocked in the
presence of respective and selective inhibitors. These results
suggest that 3-BHO can act to stimulate insulin secretion through
different pathways involving the modulation of ionic channels as
well as a crosstalk between proteins kinases signaling used to
modulate the secretorymachinery in pancreaticb-cells apparently
without cellular toxicity or hypercalcemia after in vivo treatment.
5. Conclusions
In an oral and acute treatment triterpene 3-BHO diminishes
glycaemia, stimulates GLP-1 secretion, and potentiates insulin
secretion and signiﬁcantly increase hepatic glycogen content.
Moreover, compound 3-BHO modulates intracellular calcium (by
inﬂux and from stocks) characterizing ATP-K+, Ca2+–K+ and L-VDCC
channels-dependent pathways as well as PKA and PKC activity in
pancreatic islets underlying the signaling of 3-BHO for the
secretory activity and contribution for glucose homeostasis.
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